Suppr超能文献

发作簇和长时间发作的抢救治疗更新综述。

Updated review of rescue treatments for seizure clusters and prolonged seizures.

机构信息

Department of Neurology, Stony Brook University Renaissance School of Medicine, NY, USA.

Department of Neurology, Yale School of Medicine, CT, USA.

出版信息

Expert Rev Neurother. 2022 Jul;22(7):567-577. doi: 10.1080/14737175.2022.2105207. Epub 2022 Jul 26.

Abstract

INTRODUCTION

Although the treatment of epilepsy primarily focuses on prevention, recurrent seizures are unfortunately an ongoing reality, particularly in people with epilepsy who live with chronic refractory seizures. Rescue medications are agents which can be administered in urgent/emergent seizure episodes such as seizure clusters or prolonged seizures with the goal of terminating seizure activity, preventing morbidity, and decreasing the risk of further seizures.

AREAS COVERED

This review first discusses clinical opportunities for rescue medications, with particular attention focused on seizure clusters and prolonged seizures, including their epidemiology, risk factors, and associated morbidity. Current rescue medications, their indications, efficacy, and adverse effects are discussed. We then discuss rescue medications and formulations which are currently under development, concentrating on practical aspects relevant for clinical care.

EXPERT OPINION

Rescue medications should be considered for all people with epilepsy with ongoing seizures. Recent rescue medications including intranasal formulations provide considerable advantages. New rescue medications are being developed which may expand opportunities for effective treatment. In the future, combining rescue medications with seizure detection and seizure prediction technologies should further expand opportunities for use and should reduce the morbidity of seizures and provide increased comfort, control, and quality of life for people living with epilepsy.

摘要

简介

尽管癫痫的治疗主要侧重于预防,但反复发作的癫痫仍然是一个现实问题,特别是对于那些患有慢性难治性癫痫的患者。急救药物是可以在紧急/突发癫痫发作时使用的药物,例如癫痫发作群或持续时间较长的癫痫发作,其目的是终止癫痫活动、预防发病率,并降低进一步发作的风险。

涵盖领域

本综述首先讨论了急救药物的临床应用机会,特别关注癫痫发作群和持续时间较长的癫痫发作,包括其流行病学、风险因素和相关发病率。讨论了当前的急救药物、其适应证、疗效和不良反应。然后,我们讨论了目前正在开发的急救药物和制剂,重点关注与临床护理相关的实际方面。

专家意见

应考虑对所有持续发作的癫痫患者使用急救药物。最近的急救药物,包括鼻内制剂,提供了很大的优势。正在开发新的急救药物,可能会扩大有效治疗的机会。未来,将急救药物与癫痫发作检测和预测技术相结合,应进一步扩大使用机会,并降低癫痫发作的发病率,为癫痫患者提供更多的舒适感、控制感和生活质量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验